Sickle cell patients gain a regional care framework

WHO prequalified the TAK-003 dengue vaccine on 10 May, later reporting the decision.

The prequalification supports procurement for countries with appropriate dengue vaccine policies.

The vaccine is recommended for children in particular high-transmission settings, not for every population.

The decision was one step in dengue prevention alongside mosquito control and clinical care.

New regional guidance outlined ways to improve management of sickle cell disease.

Guidance called for strengthening clinical capacity and public understanding.

The publication brought attention to patients and families facing gaps in ongoing care.

Chad eliminated the gambiense form of human African trypanosomiasis as a public health problem.

Surveillance and access to diagnosis and treatment supported Chad’s achievement.

The WHO validation concerned a specific form of sleeping sickness and a defined public health threshold.